Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Lasers in Medical Science
Published in: Lasers in Medical Science 6/2020

01-08-2020 | Alopecia | Review Article

Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia

Authors: Hassan Galadari, Swathi Shivakumar, Torello Lotti, Uwe Wollina, Andy Goren, Ghasem Rahmatpour Rokni, Stephan Grabbe, Mohamad Goldust

Published in: Lasers in Medical Science | Issue 6/2020

Login to get access

Abstract

Androgenetic alopecia (AGA), also termed as androgenic alopecia or common baldness, is a condition where there is androgen mediated conversion of susceptible terminal hair into vellus hair. Although it is reported more commonly in males, it also affects females but the incidence is relatively unknown. AGA tremendously affects the psychology of the patient due to its chronicity of treatment and cosmetic implications. There are numerous treatment options available for AGA but the choice of treatment has to often be tailored according to the patient’s needs, affordability, and compliance. This review focusses on the various treatment options available, with special emphasis on the role of low-level laser therapy (LLLT) in the management of AGA. The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles. Only articles available in English were considered for this review.
Literature
1.
Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53(3):708–728PubMed
2.
Otberg N, Finner AM, Shapiro J (2007) Androgenetic Alopecia. Endocrinol Metab Clin N Am 36(2):379–398
3.
Paus R, Cotsarelis G. The biology of hair follicles. Epstein FH, editor. N Engl J Med 1999;341(7):491–497
4.
Rousso DE, Kim SW (2014) A review of medical and surgical treatment options for androgenetic alopecia. JAMA Facial Plast Surg 16(6):444PubMed
5.
Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR (2014) Low-level laser (light) therapy (LLLT) for treatment of hair loss: LLLT for hair regrowth. Lasers Surg Med 46(2):144–151PubMed
6.
Faghihi G, Mozafarpoor S, Asilian A, Mokhtari F, Esfahani A, Bafandeh B et al (2018) The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol 84(5):547PubMed
7.
Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39(4):578–589PubMed
8.
Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D et al (2000) Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 143(4):804–810PubMed
9.
Caserini M, Radicioni M, Leuratti C, Terragni E, Iorizzo M, Palmieri R (2016) Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther 54(01):19–27PubMed
10.
Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9(11):2927–2932PubMed
11.
12.
Hajheydari Z, Akbari J, Saeedi M, Shokoohi L (2009) Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol 75(1):5
13.
Drobnis EZ, Nangia AK (2017) 5α-reductase inhibitors (5ARIs) and male reproduction. Adv Exp Med Biol 1034:59–61PubMed
14.
Tsunemi Y, Irisawa R, Yoshiie H, Brotherton B, Ito H, Tsuboi R et al (2016) Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. J Dermatol 43(9):1051–1058PubMed
15.
Prager N, Bickett K, French N, Marcovici G (2002) A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 8(2):143–152
16.
Rossi A, Mari E, Scarnò M, Garelli V, Maxia C, Scali E et al (2012) Comparitive effectiveness and finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol 25(4):1167–1173PubMed
17.
Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M (2002) Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg 28(8):678–685PubMed
18.
Rathnayake D, Sinclair R (2010) Male androgenetic alopecia. Expert Opin Pharmacother 11(8):1295–1304PubMed
19.
Goren A, Sharma A, Dhurat R, Shapiro J, Sinclair R, Situm M et al (2018) Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Dermatol Ther 31(6):e12741PubMed
20.
Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S (2012) Minoxidil use in dermatology, side effects and recent patents. Recent Patents Inflamm Allergy Drug Discov 6(2):130–136
21.
Bienová M, Kuerová R, Fiurá M (2005) Androgenetic alopecia and current methods of treatment. Androg Alopecia 14(1):4
22.
Senel E, Purnak T, Sahin C (2011) Liquid formulation of minoxidil versus its foam formulation. Indian J Dermatol 56(4):462PubMedPubMedCentral
23.
Blumeyer A, Tosti A, Messenger A, Reygagne P, del Marmol V, Spuls PI et al (2011) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG J Dtsch Dermatol Ges 9:S1–S57PubMed
24.
Gupta AK, Charrette A (2015) Topical minoxidil: systematic review and meta-analysis of its efficacy in androgenetic alopecia. Skinmed. 13(3):185–189PubMed
25.
Chitalia J, Dhurat R, Goren A, McCoy J, Kovacevic M, Situm M et al (2018) Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian subcontinent. Dermatol Ther 31(6):e12688PubMed
26.
Goren A, Shapiro J, Roberts J, McCoy J, Desai N, Zarrab Z et al (2015) Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther 28(1):13–16PubMed
27.
Li ZJ, Choi H-I, Choi D-K, Sohn K-C, Im M, Seo Y-J et al (2012) Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 38(7pt1):1040–1046PubMed
28.
Lotti T, Goren A, Verner I, D’Alessio PA, Franca K (2019) Platelet rich plasma in androgenetic alopecia: a systematic review. Dermatol Ther 32(3):e12837PubMed
29.
Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG et al (2014) The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014:1–9
30.
Puig CJ, Reese R, Peters M (2016) Double-blind, Placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg 42(11):1243–1247PubMed
31.
Ayatollahi A, Hosseini H, Shahdi M, AhmadNasrollahi S, NassiriKashani M, Yadangi S et al (2017) Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment? Indian Dermatol Online J 8(6):460–464PubMedPubMedCentral
32.
Stevens J, Khetarpal S (2019) Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol 5(1):46–51PubMed
33.
34.
Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G et al (2016) Multi-therapies in androgenetic alopecia: review and clinical experiences: an update and future potential treatments. Dermatol Ther 29(6):424–432PubMed
35.
Patwardhan N, Mysore V (2008) Hair transplantation: standard guidelines of care. Indian J Dermatol Venereol Leprol 74(Suppl):S46–53
36.
Kassimir JJ (1987) Use of topical minoxidil as a possible adjunct to hair transplant surgery. J Am Acad Dermatol 16(3):685–687PubMed
37.
Leavitt M, David P-M, Rao NA, Barusco M, Kaufman KD, Ziering C (2006) Effects of finasteride (1 mg) on hair transplant. Dermatol Surg 31(10):1268–1276
38.
Dhurat R, Mathapati S (2015) Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy. Indian J Dermatol 60(3):260PubMedPubMedCentral
39.
Verner I, Lotti T (2018) Clinical evaluation of a novel fractional radiofrequency device for hair growth: fractional radiofrequency for hair growth stimulation. Dermatol Ther 31(3):e12590PubMed
40.
Maddin WS, Bell PW, James JH (1990) The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis Int J Dermatol 29(6):446–450PubMed
41.
Doghaim NN, El-Tatawy RA, Neinaa YME, Abd El-Samd MM (2018) Study of the efficacy of carboxytherapy in alopecia. J Cosmet Dermatol 17(6):1275–1285PubMed
42.
Ghanaat M (2010) Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. South Med J 103(9):917–921PubMed
43.
Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR et al (2014) Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, Double-blind Study. Am J Clin Dermatol 15(2):115–127PubMedPubMedCentral
44.
Kruglikov IL, Zhang Z, Scherer PE (2019) The role of immature and mature adipocytes in hair cycling. Trends Endocrinol Metab 30(2):93–105PubMed
45.
Leavitt M, Charles G, Heyman E, Michaels D (2009) HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled. Multicentre Trial Clin Drug Investig 29(5):283–292PubMed
46.
Kim H, Choi JW, Kim JY, Shin JW, Lee S, Huh C-H (2013) Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, Sham Device–Controlled Multicenter Trial. Dermatol Surg 39(8):1177–1183PubMed
47.
Suchonwanit P, Chalermroj N, Khunkhet S (2019) Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci 34(6):1107–1114PubMed
48.
Mai-Yi Fan S, Cheng Y-P, Lee M-Y, Lin S-J, Chiu H-Y (2018) Efficacy and safety of a low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, self-comparison, sham device-controlled trial. Dermatol Surg Off Publ Am Soc Dermatol Surg Al 44(11):1411–1420
49.
Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fernandez-Obregon A, Kazmirek ER (2013) The growth of human scalp hair mediated by visible red light laser and LED sources in males: the growth of human scalp hair. Lasers Surg Med 45(8):487–495PubMed
50.
Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA (2014) The growth of human scalp hair in females using visible red light laser and LED sources: growth of scalp hair in women. Lasers Surg Med 46(8):601–607PubMed
Metadata
Title
Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia
Authors
Hassan Galadari
Swathi Shivakumar
Torello Lotti
Uwe Wollina
Andy Goren
Ghasem Rahmatpour Rokni
Stephan Grabbe
Mohamad Goldust
Publication date
01-08-2020
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 6/2020
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-020-02994-4

Other articles of this Issue 6/2020

Lasers in Medical Science 6/2020 Go to the issue

Original Article

Dual effect of blue light on Fusariumsolani clinical corneal isolates in vitro

Review Article

Er:YAG laser for snoring: a systemic review and meta-analysis

Brief Report

Light emitting diode (LED) based fluorescence microscopy for tuberculosis detection: a review

Original Article

Higher implantation and live birth rates with laser zona pellucida breaching than thinning in single frozen-thawed blastocyst transfer

Letter to the Editor

Pulsed dye laser to treat cutaneous sarcoid

Original Article

The effect of electric field, magnetic field, and infrared ray combination to reduce HOMA-IR index and GLUT 4 in diabetic model of Mus musculus